This Article  • References  • Full text PDF  • Correction  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (16)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Schladming, Austria, Jan 26-31, 1986

Lynn E. DeLisi, MD; Timothy J. Crow, MB, PhD; Steven R. Hirsch, MD

Arch Gen Psychiatry. 1986;43(7):706-711.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Several decades have passed since Kraepelin defined dementia praecox as a separate clinical syndrome, yet little advancement in our knowledge of its etiology has occurred. While major pharmacological treatment strategies have been established, only a diverse array of isolated multiple positive findings that give clues to its pathogenesis have emerged. Reports and hypotheses meriting further pursuit are buried within a pile of unconfirmed, often artifactual published data. Workshops for formulating and debating the merits of hypotheses for the pathogenesis and treatment of schizophrenia are far too few, despite the plethora of annual meetings devoted to psychiatric problems.

T. J. Crow and S. R. Hirsch, from the United Kingdom, have been the organizers of a unique biannual workshop addressing these issues. They assemble an international group of investigators whose methodological expertise varies widely, but whose interests remain focused on schizophrenia. The January 1984 session similarly conducted in Davos, Switzerland, was previously . . . [Full Text PDF of this Article]

Author Affiliations
From the Clinical Neurogenetics Branch, National Institute of Mental Health, Bethesda, Md.

Footnotes
Accepted for publication March 5, 1986.

All information in this article has been synthesized from Dr DeLisi's meeting notes and is her impression of the data and conclusions presented.

Some, but not all, of the information has been verified by the author in further conversations and correspondence with individual meeting participants. Conclusions and interpretations are her opinions except where noted.

Reprint requests to Clinical Neurogenetics Branch, National Institute of Mental Health, Room 3N/220, Bldg 10, National Institutes of Health, Bethesda, MD 20892 (Dr DeLisi).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?